Radiolabeling of biodegradable polymeric microspheres with [ 99mTc(CO)3]+ and in vivo biodistribution evaluation using microSPECT/CT imaging

Bioconjugate Chemistry

Volumn 20, Issue 6, 2009, Pages 1209-1217

  Saatchi, Katayoun ^a   Häfeli, Urs O ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN COLLOID TC 99M; ANTIMONY SULFUR COLLOID TC 99M; CHROMIC PHOSPHATE COLLOID P 32; DIHYDROGEN TRIOXIDE TRICARBONYL TC 99M; MACROSALB TC 99M; MICROSPHERE TC 99M; MICROSPHERE Y 90; POLYLACTIDE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM SULFUR COLLOID TC 99M; TRICARBONYL TC 99M; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG DISTRIBUTION; DRUG STRUCTURE; FEMALE; IN VIVO STUDY; ISOTOPE LABELING; MOUSE; NONHUMAN; RETICULOENDOTHELIAL SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

MURINAE;

EID: 67649200182     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc900066j     Document Type: Article

References (35)

1. Saha, G. B. (2004) Fundamentals of nuclear pharmacy, 5th ed., Springer, New York.
2. Rhodes, B. A., Zolle, I., Buchanan, J. W., and Wagner, H. N. (1969) Radioactive albumin microspheres for studies of the pulmonary circulation. Radiology 92, 1453-1460.
3. Davis, M. A. (1975) Particulate radiopharmaceuticals for pulmonary studies, in Radiopharmaceuticals (Subramaniam, B., Rhodes, B., Cooper, D. R., Sodd, V. J., Eds.) pp 267-281, Society of Nuclear Medicine, Reston, VA.
4. Sty, J. R., and Conway, J. J. (1985) The spleen: development and functional evaluation. Semin. Nucl. Med. 15, 276-298.
5. Desai, A. G., and Thakur, M. L. (1985) Radiopharmaceuticals for spleen and bone marrow studies. Semin. Nucl. Med. 15, 229-238
6. Toki, H., Hersh, E. M., Murphy, S., Glenn, H., Haynie, T. P., and White, R. A. (1981) Use of mini-microaggregated albumin to study reticuloendothelial system (RES) function in C. parvum-treated animals. Int. J. Immunopharmacol. 3, 147-152 (Pubitemid 11122998)
7. 99mTc in the evaluation of the removal capacity of the reticuloendothelial system. Eur. J. Nucl. Med. 13, 254-257.
8. Mirzaei, S., Knoll, P., Hoffmann, B., Kreuzer, W., and Kohn, H. (2001) Optimized mammary lymphoscintigraphy using larger colloid particles. J. Nucl. Med. 42, 826. (Pubitemid 32453476)
9. 99mTc. Acta Oncol. 46, 105-110.
10. Zhao, H., Saatchi, K., and Häfeli, U. O. (2009) Preparation of biodegradable magnetic microspheres with poly(lactic acid) coated magnetite. J. Magn. Magn. Mater. 321, 1356-1363.
11. Schneider, T., Zhao, H., Jackson, J. K., Chapman, G. H., Dykes, J., and Häfeli, U. O. (2008) Use of hydrodynamic flow focusing for the generation of biodegradable camptothecin-loaded polymer microspheres. J. Pharm. Sci. 97, 4943-4954.
12. Saatchi, K., and Häfeli, U. O. (2007) One-pot syntheses, coordination and characterization of application-specific biodegradable ligand-polymers. Dalton Trans. 39, 4439-4445. (Pubitemid 47512906)
13. Zastre, J., Jackson, J., Bajwa, M., Liggins, R., Iqbal, F., and Burt, H. (2002) Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by Caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers. Eur. J. Pharm. Biopharm. 54, 299-309. (Pubitemid 35341830)
14. Egli, A., Alberto, R., Tannahill, L., et al. (1999) Organometallic Tc-99m-aquaion labels peptide to an unprecedented high specific activity. J. Nucl. Med. 40, 1913-1917. (Pubitemid 29523588)
15. +. J. Am. Chem. Soc. 123, 3135-3136.
16. + retains biological activity in vitro. Nucl. Med. Biol. 28, 243-250.
17. Petrig, J., Schibli, R., Dumas, C., Alberto, R., and Schubiger, P. A. (2001) Derivatization of glucose and 2-deoxyglucose for transition metal complexation: substitution reactions with organometallic 99mTc and Re precursors and fundamental NMR investigations. Chemistry 7, 1868-1873 (Pubitemid 32433651)
18. Waibel, R., Treichler, H., Schaefer, N. G., et al. (2008) New derivatives of vitamin B12 show preferential targeting of tumors. Cancer Res. 68, 2904-2911 (Pubitemid 351556290)
19. Zhao, H., Gagnon, J., Häfeli, U. O. (2007) Process and formulation variables in the preparation of injectable and biodegradable magnetic microspheres. Biomagn. Res. Technol. 5:2. (Pubitemid 46996125)
20. Cleland, J. L. (1998) Solvent evaporation processes for the production of controlled release biodegradable microsphere formulations for therapeutics and vaccines. Biotechnol. Prog. 14, 102-107. (Pubitemid 28118270)
21. Arshady, R., Monshipouri, M. (2001) Targeted delivery of microparticulate carriers: particle size controlled targeting, in Microspheres, Microcapsules & Liposomes: Medical & Biotechnology Applications, (Arshady, R., Ed.) pp 410-414, Vol MML2, Kentus, London.
22. 99mTc-labeled antibodies? Nucl. Med. Biol. 21, 1035-1044
23. Causey, P. W., Besanger, T. R., Schaffer, P., and Valliant, J. F. (2008) Expedient multi-step synthesis of organometallic complexes of Tc and Re in high effective specific activity. A new platform for the production of molecular imaging and therapy agents. Inorg. Chem. 47, 8213-8221
24. Scheffel, U., Rhodes, B. A., Natarajan, T. K., and Wagner, H. N. (1972) Albumin microspheres for study of the reticuloendothelial system. J. Nucl. Med. 13, 498-503.
25. Tanaka, T., Shiramoto, S., Miyashita, M., Fujishima, Y., and Kaneo, Y. (2004) Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME). Int. J. Pharm. 277, 39-61. (Pubitemid 38670420)
26. Wattendorf, U., and Merkle, H. P. (2008) PEGylation as a tool for the biomedical engineering of surface modified microparticles. J. Pharm. Sci. 97, 4655-4669
27. Baker, H. M., Baker, C. J., Smith, C. A., and Baker, E. N. (2000) Metal substitution in transferrins: specific binding of cerium(IV) revealed by the crystal structure of cerium-substituted human lactoferrin. J. Biol. Inorg. Chem. 5, 692-698 (Pubitemid 30846478)
28. Sun, H., Li, H., and Sadler, P. J. (1999) Transferrin as a metal ion mediator. Chem. Rev. 99, 2817-2842
29. 99mTc-furifosmin: relative retention and clearance kinetics in retrogradely perfused guinea pig hearts. Nucl. Med. Biol. 29, 243-254
30. 99mTc-labeled and unlabeled antimony trisulfide and rhenium sulfide colloids intended for lymphoscintigraphic application. J. Nucl. Med. 42, 460-466.
31. Harbert, J. C. (1996) Radiocolloid therapy of cystic brain tumors, in Nuclear medicine: Diagnosis and therapy (Harbert, J. C., Eckelman, W. C., and Neumann, R. D., Eds.) pp 1083-1091, Thieme Medical Publishers, New York.
32. Nolan, T. R., Grady, E. D., Crumbley, A. J., Larose, J. H., and Cheek, W. V. (1975) Internal hepatic radiotherapy: I. Organ distribution of colloid Cr-(P-32)PO4 injected into a peripheral vein, the portal vein, or the arterial supply of the gastrointestinal tract in the rat. Am. J. Roentg. Rad. Ther. Nucl. Med. 124, 590-595.
33. Anghileri, L. J. (1968) Studies on colloidal chromic phosphate: an improved method of preparation and in situ precipitation by injection of papain. Int. J. Appl. Radiat. Isot. 19, 415-420
34. Salem, R., and Hunter, R. D. (2006) Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review. Int. J. Radiat. Oncol. Biol. Phys. 66, S83-S88. (Pubitemid 44353960)
35. Kennedy, A., Nag, S., Salem, R., et al. (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int. J. Radiat. Oncol. Biol. Phys. 68, 13-23. (Pubitemid 46589861)